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What’s already known about this topic? 
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Pathogenic anti-desmoglein (Dsg) 3 monoclonal antibodies (mAbs) recognize the calcium 
(Ca2+)-dependent conformational epitopes. 
Pemphigus vulgaris (PV) sera contain antibodies against a variety of different epitopes of 
Dsg3. 
The combination of mAbs against the different epitopes induced stronger pathogenicity 
than a single mAb. 
Anti-Dsg3 serum antibody titers are usually correlated with the disease activity of PV, 
but some patients have nonpathogenic anti-Dsg3 serum antibodies. 
(63 words) 
 
What does this study add? 
We have developed ethylenediaminetetraacetic acid (EDTA) treated enzyme-linked 
immunosorbent assay (ELISA), which can distinguish anti-Dsg3 antibodies against 
Ca2+-dependent from non-Ca2+-dependent epitopes easily. 
EDTA-treated ELISA revealed that the proportion of anti-Dsg3 serum antibodies against 
the Ca2+-dependent epitopes decreased after entering the inactive phase in PV patients. 
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EDTA-treated ELISA can detect nonpathogenic anti-Dsg3 serum antibodies against the 
non-Ca2+-dependent epitopes, and also be useful for monitoring the disease activity in PV 
patients. 
(69 words) 
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Abstract 
Background Anti-desmoglein (Dsg) 3 serum antibody titers are usually correlated with the 
disease activity of pemphigus vulgaris (PV), but some patients retain high titers even in 
remission. 
Objectives The aim of our study was to determine whether anti-Dsg3 antibodies in PV sera 
recognized calcium (Ca2+)-dependent or non-Ca2+-dependent epitopes, and evaluate their 
pathogenicity. 
Methods Dsg3 baculoprotein-coated enzyme-linked immunosorbent assay (ELISA) plates 
were treated with 0.5 mM ethylenediaminetetraacetic acid (EDTA). The binding ability of 
anti-Dsg3 monoclonal antibodies (mAbs) was analyzed. Eight of the 83 PV patients 
screened had elevated Dsg3 ELISA index values greater than 100 index values in remission. 
The binding ability of those PV sera was analyzed. We evaluated the pathogenicity of 
anti-Dsg3 serum antibodies against the non-Ca2+-dependent epitopes using dissociation 
assay. 
Results The reactivity of pathogenic anti-Dsg3 mAbs against the Ca2+-dependent epitopes 
diminished markedly in EDTA-treated ELISA, whereas no such reduction was observed in 
mAbs against the non-Ca2+-dependent epitopes. All patients’ sera contained antibodies 
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against both Ca2+-dependent and non-Ca2+-dependent epitopes. In 6 out of the 8 patients, 
the ratio of antibodies against Ca2+-dependent to non-Ca2+-dependent epitopes decreased in 
remission. EDTA-treated Dsg3 baculoproteins adsorbed anti-Dsg3 serum antibodies 
against the non-Ca2+-dependent epitopes, but the remnant PV antibodies retained the 
ability to induce acantholysis in dissociation assay. 
Conclusions We have established an assay to indirectly measure the titers of anti-Dsg3 
serum antibodies against the Ca2+-dependent epitopes, which are the differences between 
EDTA-untreated and EDTA-treated ELISA index values, as a routine laboratory test to 
reflect the pathogenic anti-Dsg3 serum antibody titers more accurately. 
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Introduction 
PV is an autoimmune blistering disease, characterized by the loss of cell-cell adhesion 
between epidermal keratinocytes and the presence of autoantibodies against Dsg3. The 
binding of autoantibodies to Dsg3 causes endocytosis of Dsg3 from the cell surface, and 
results in the formation of Dsg3-depleted desmosomes which is weak adhesive desmosome 1, 
and can lead to desmosomal dissociation 2-5. However, the mechanisms of desmosomal 
dissociation are not fully understood and multiple pathways may be involved in 
acantholysis in a coordinated manner. 
Dsgs, desmosomal members of the cadherin superfamily, contain four cadherin repeats of 
approximately 110 amino acids (extracellular domains (EC) 1-4) and an extracellular 
anchor (EC5) in the amino-terminal ectodomain 6. The adhesive properties of 
cadherin-family proteins mainly involve the EC1 and EC2, and the junctions between these 
domains are characterized by Ca2+ binding sites 7. Ca2+ is essential for the correct 
functioning of cadherins 8-11. A previous study showed that pathogenic AK23 and AK19 
mAbs which bind to the EC1-2 of Dsg3 in a Ca2+-dependent manner were capable of 
inducing acantholysis, while other mAbs AK18, AK15, and AK20 which bind to the EC2-5 
Ca2+-independently were not (Fig. 1) 12. Interestingly, anti-Dsg3 antibodies which bind to 
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the non-Ca2+-dependent epitopes did not induce acantholysis alone, but enhanced 
acantholysis synergistically in the presence of anti-Dsg3 antibodies against the 
Ca2+-dependent epitopes 13. Therefore, it is hard to avoid the impression that the epitopes of 
antibodies should be a key factor in their pathogenicity as well as their titers. 
In PV patients, the titers of anti-Dsg serum antibodies, as measured by conventional 
ELISA, generally correlate with the disease activity, and are proportional to the severity of 
the disease, especially when monitored in individual patients 14-15. In some cases, however, 
anti-Dsg3 serum antibody titers remain high even though the disease is clinically inactive 
16-17. Conventional ELISA is a serological laboratory test for determining the binding 
capacity of autoantibodies against a whole Dsg3 molecule containing the EC1-5, and cannot 
distinguish the epitopes. In order to address the discrepancy between anti-Dsg3 serum 
antibody titers and the clinical course, we analyzed the epitope types recognized by 
anti-Dsg3 antibodies in PV sera. We distinguished the titers of anti-Dsg3 antibodies 
against Ca2+-dependent epitopes from non-Ca2+-dependent epitopes using commercially 
available Dsg3 ELISA plates with EDTA-treatment. Because Ca2+ maintains the 
conformational structure of Dsg3, the ELISA plate was treated with EDTA so that the 
conformational structure of Dsg3 coated on the ELISA plate could be modified. We 
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examined whether this assay was more sensitive than conventional ELISA at detecting 
pathogenic antibodies in both in vitro and clinical situations. 
 
Materials and methods 
Anti-Dsg3 mAbs 
Anti-Dsg3 mAbs (AK15, 18, 19, 20, 23) were produced by hybridoma cells from 
splenocytes isolated from PV model mice, as previously described 12. 
 
PV patients’ sera 
We retrospectively reviewed 83 PV patients who were treated between January 2003 and 
December 2009. Serum samples stocked during the clinical courses were used. Of 83 PV 
patients screened, 8 patients had elevated Dsg3 ELISA index values greater than 100 index 
values in the inactive phase, which was defined as the absence of new and/or established 
lesions on the skin and mucosa while treated with 10 mg/day of prednisolone or less (or the 
equivalent) for at least 2 months, according to the consensus statement 18. 
  
EDTA-treated ELISA and conformational ELISA index value 
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Immunoreactivity was evaluated using Dsg ELISA according to the kit manufacturer’s 
instructions (MBL, Nagoya, Japan). In order to modify the Ca2+-dependent epitopes of Dsg3 
molecules coated on the ELISA plate, the plates were treated with 0.5 mM EDTA for 30 
minutes at room temperature as previously reported 19. After washing 4 times with Dsg 
ELISA wash buffer, the conventional assay protocol was carried out. The modified 
structure of Dsg3 molecules cannot be restored after EDTA-treatment because kit reagents 
are free from Ca2+ throughout the ELISA process. Both EDTA-untreated and 
EDTA-treated ELISA were performed with same samples at once. The differences between 
EDTA-untreated and EDTA-treated ELISA index values were calculated as conformational 
ELISA index values. Conformational ELISA index values did not reflect antibodies against 
the non-Ca2+-dependent epitopes, but against the Ca2+-dependent epitopes. 
 
IgG purification 
IgG fractions were isolated using HiTrap Protein G columns (GE Healthcare, Tokyo, 
Japan). ELISA index values of purified IgG containing 30 μg protein were determined. 
  
Dissociation assay 
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The adhesive strength of DJM-1 cell-cell contacts was assayed based on an adapted 
method that modified previously described methods 13,20-21. DJM-1 cells, a cell line isolated 
from human skin squamous cell carcinoma 22, were seeded in 12 well dishes and cultured 
until they reached confluence 13. The cells were then stimulated with 300 μg of purified 
PV-IgG and incubated at 37°C for 8 hours or 24 hours. For the dose-response experiments, 
each well was filled with 1 ml of medium containing PV-IgG ranging from 0.032 to 1000 
μg/ml. After washing with PBS twice, cells were incubated with dispase for 30 minutes to 
detach the cell sheet from the bottom of the dish, and mechanical stress was applied by 
pipetting the cells 5 times with a P1000 Pipetman. The resulting dissociated cells were 
fixed by adding formaldehyde to a final concentration of 3%, stained with crystal violet. 
Then, the dishes were centrifuged at 2000 g for 5 minutes and the number of cell 
fragmentations was counted. Each experiment was carried out in triplicate. 
 
Ca2+-supplemented and Ca2+-depleted Dsg3 baculoproteins 
Dsg3 recombinant proteins were produced as previously described 12,23. To examine the 
effects of Ca2+-depletion, we added 5 mM EDTA to supernatants containing Dsg3 
baculoproteins. Samples were incubated for 1 hour at room temperature and then dialyzed 
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against phosphate buffered saline (PBS) without Ca2+. To determine whether the effects 
associated with Ca2+-depletion were reversible, samples were dialyzed against 1 mM CaCl2 
in PBS (PBS-Ca) after 1-hour incubation at room temperature with 5 mM EDTA. 
 
Adsorption of the PV serum to Dsg3 baculoproteins 
To examine the effects Ca2+-supplemented and Ca2+-depleted Dsg3 baculoproteins have 
on adsorption, PV-IgG containing 300 µg protein were incubated with each Dsg3 
baculoprotein containing 18000 µg protein for 30 minutes at room temperature, then 
subjected to dissociation assay, as described above. Each experiment was carried out in 
duplicate. 
 
Results 
Effects of EDTA-treatments to the Dsg3 molecules on the ELISA plate 
To characterize the conformational change of 0.5 mM EDTA-treated Dsg3 recombinant 
protein, we first examined the affinity of five AK mAbs (Figs 1-2). The reduction rate of 
AK23 and AK19 mAbs, which bind to the EC1-2 of Dsg3, were 65.5–84.4% and 72.3–79.1% 
respectively. AK18 and AK15 mAbs, which bind to the EC2-4, showed a 72.3–79.1% and 
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11.8–43.9% reduction respectively. The decrease observed with AK18 mAb was equal to 
AK23 and AK19 mAbs, whereas the decrease observed with AK15 mAb was not as high as 
AK23 and AK19 mAbs. It is noteworthy that AK20 mAb, which binds to the EC4-5, did not 
show any reduction at all. The reduction rate of all AK mAbs was almost the same when 
ELISA plates were pretreated with 0.5 mM EDTA for 60 minutes or 5 mM EDTA for 30 
minutes (data not shown). These results suggest that EDTA-treatment changed the whole 
structure of EC1-2 recognized by AK23 and AK19 mAbs, and a part of EC2-4 recognized by 
AK18 and AK15 mAbs, but could not change the structure of EC4-5 recognized by AK20 
mAb. 
 
Immunoreactivity of PV patients’ sera against the EDTA-treated recombinant Dsg3 
We next analyzed the composition of anti-Dsg3 antibodies detected in PV patients’ sera. 
We performed Dsg3 ELISA with and without EDTA-treatment using 8 PV patients’ sera 
(Table 1). Anti-Dsg3 serum antibody titers, indicated as conventional ELISA index values, 
decreased but remained high after entering the inactive phase in 6 patients (Fig. 3, Table 1, 
cases 1, 2, 3, 6, 7, and 8). On the other hand, anti-Dsg3 serum antibody titers increased in 2 
patients (Fig. 3, Table 1, cases 4 and 5), even in the inactive phase. Anti-Dsg3 serum 
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antibody titers in these cases did not correlate with the disease activity. In cases 1, 2, 3, 6, 7, 
and 8, both conventional Dsg3 ELISA index values and conformational Dsg3 ELISA index 
values were decreased in the inactive phase (Fig. 3, Table 1). By contrast, in cases 4 and 5, 
conventional Dsg3 ELISA index values were increased, whereas conformational Dsg3 
ELISA index values were decreased. The ratio of anti-Dsg3 serum antibodies recognizing 
Ca2+-dependnet and non-Ca2+-dependent epitopes was determined (Fig. 4). Anti-Dsg3 
serum antibodies against the non-Ca2+-dependent epitopes were detected at a higher rate 
in the inactive phase. The proportion of antibodies against the Ca2+-dependent epitopes 
decreased in 6 out of the 8 patients in the inactive phase. By contrast, the proportion of 
antibodies against the Ca2+-dependent epitopes increased in 2 patients, cases 7 and 8. All 
patients’ sera contained anti-Dsg3 serum antibodies against both Ca2+-dependent and 
non-Ca2+-dependent epitopes. 
 
Evaluation of pathogenic correlation of conformational ELISA index value as examined by 
dissociation assay. 
  To evaluate the pathogenic correlation of conformational ELISA index value in clinical 
cases, the pathogenicities of purified IgG from PV patients’ sera with same conventional 
Dsg3 ELISA index values but different EDTA-treated Dsg3 ELISA index values were 
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compared by dissociation assay (Table 2a). A serum of case 1 was obtained in the active 
phase, while a serum of case 2 was obtained in the inactive phase. In case 1, anti-Dsg3 
serum-IgG showed 33.6 index value by conventional ELISA and 8.9 index value by 
EDTA-treated ELISA. Calculated conformational Dsg3 ELISA index value was 24.7 index 
value. Therefore, total anti-Dsg3 antibodies contained approximately 73.5 % of IgG against 
the Ca2+-dependent epitopes. By contrast, anti-Dsg3 serum-IgG of case 2 contained no IgG 
against the Ca2+-dependent epitopes. DJM-1 cells, cultured as monolayer sheets, were 
incubated for 8 hours with each purified IgG containing 0.032, 0.16, 0.8, 4, 100, 500, and 
1000 μg/ml. IgG of PV case 1 showed dose-dependent reactivity between 4 and 1000 μg/ml, 
whereas IgG of PV case 2 did not induce fragmentations of the cell sheet at all (Fig. 5). As 
for IgG of PV case 2, fragmentations of the cell sheet were not induced despite the 
incubation for 24 hours (data not shown). These results indicated that conformational 
ELISA index values reflected the pathogenicity of anti-Dsg3 serum-IgG. 
We next examined the effects of anti-Dsg3 serum-IgG against the non-Ca2+-dependent 
epitopes on disruption of intercellular adhension. Purified IgG from 4 serum samples of 2 
PV patients with same conformational Dsg3 ELISA index values but different 
EDTA-treated Dsg3 ELISA index values were examined by dissociation assay (Table 2b). 
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Cell sheets were incubated with each purified IgG for 8 hours (Fig. 6a) and 24 hours (Fig. 
6b). The number of cell fragmentations incubated with IgG No. 1-4 did not increase after 
the incubation for 8 hours. However, the number of cell fragmentations incubated with IgG 
No. 1 and 2 increased after the incubation for 24 hours in similar extent. On the other hand, 
the number of cell fragmentations incubated with IgG No. 3 and 4 did not increase at all 
despite the incubation for 24 hours. These results indicated that anti-Dsg3 serum-IgG 
against the non-Ca2+-dependent epitopes did not enhance the pathogenicity in dissociation 
assay. 
 
Pathogenicity of autoantibodies against the non-Ca2+-dependent epitopes of Dsg3 as 
examined by dissociation assay 
To elucidate the pathogenicity of antibodies against the non-Ca2+-dependent epitopes of 
Dsg3, we performed dissociation assay using the PV-IgG adsorbed with Dsg3 
baculoproteins with or without EDTA-treatment. We used anti-Dsg3 serum-IgG, which 
showed 278.6 index value by conventional ELISA and 178.9 index value by conformational 
ELISA. The alteration of ELISA index values of anti-Dsg3 serum-IgG after 
immunoadsorption with each Dsg3 baculoprotein was analyzed. Both untreated Dsg3 
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baculoproteins and EDTA-treated Dsg3 baculoproteins dialyzed against PBS-Ca completely 
blocked the immunoreactivity with 30µg of anti-Dsg3 serum-IgG at the higher amounts 
than 1800 µg (Fig. 7). By contrast, 1800 µg of EDTA-treated Dsg3 baculoproteins was 
sufficient to achieve complete immunoadsorption of antibodies against the 
non-Ca2+-dependent epitopes of Dsg3, because the immunoreactivity reached nearly equal 
to conformational Dsg3 ELISA index value. These adsorptive effects were also observed as 
examined by indirect immunofluorescence (data not shown). Cultured keratinocytes were 
stimulated for 24 hours. Cell sheets, incubated with EDTA-treated Dsg3-adsorbed 
anti-Dsg3 serum-IgG, dissociated into numerous smaller fragments, with the number of 
fragments nearly equal to that of the positive control (Fig. 8). These results indicated that 
EDTA-treated Dsg3 baculoproteins did not block the pathogenicity of anti-Dsg3 serum-IgG, 
and antibodies against the non-Ca2+-dependent epitopes of Dsg3 did not have an intimate 
involvement in the fragmentation of dissociation assay. On the other hand, untreated 
Dsg3-adsorbed anti-Dsg3 serum-IgG did not cause fragmentations of the cell sheets. The 
same result was obtained after treatment with Dsg3 baculoproteins dialyzed against 
PBS-Ca. 
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Discussion 
To characterize the Dsg3 epitopes involved in binding, we first examined five anti-Dsg3 
mAbs (AK15, 18, 19, 20, 23). EDTA-treatment reduced the reactivity of all AK mAbs except 
for AK20 mAb. The reactivity of each AK mAb also varied with its concentration. It is 
possible that each AK mAb has a different binding affinity for the Ca2+-dependent epitopes 
of Dsg3. Our finding that AK23 mAb associates with Dsg3 at low concentrations 
demonstrates that it has a high affinity for Dsg3. The epitopes of AK23 and AK19 mAbs are 
present in the EC1-2 of Dsg3 (Fig. 1), and AK23 and AK19 mAbs could not bind to the 
EDTA-treated Dsg3. These results indicate that the conformational structures of the EC1-2 
of Dsg3 are Ca2+-dependent. The epitopes of AK18 and AK15 mAbs are present in the 
EC2-4 (Fig. 1). The binding of AK18 and AK15 mAbs was also diminished for the 
EDTA-treated Dsg3. However, as the concentration of the antibodies increased, the binding 
of these AK mAbs to Dsg3 also increased, suggesting that Ca2+-dependent conformational 
structures of the epitopes recognized by AK18 and AK15 mAbs were a little changed 
because AK18 and AK15 mAbs bound to the EDTA-treated ELISA plates with less affinity. 
The pathogenesis of pemphigus is thought to be defined by various factors, such as 
antibody titer, the epitopes involved in binding, and the predominant IgG subclasses 
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involved. In some PV patients, Dsg3 ELISA index values remain high even in remission 
16-17, suggesting that positive ELISA index values reflect the nonpathogenic anti-Dsg3 
serum antibodies. We examined sera obtained from 8 PV patients whose ELISA index 
values were persistently high in remission. All patients’ sera contained antibodies against 
both Ca2+-dependent and non-Ca2+-dependent epitopes of Dsg3. The proportion of 
antibodies against the Ca2+-dependent epitopes decreased in 6 out of the 8 patients. This 
result indicated that there were more antibodies against the Ca2+-dependent epitopes in 
the active phase, and more antibodies against the non-Ca2+-dependent epitopes remained 
in the inactive phase. In these cases, clinical improvement was observed especially when 
antibodies against the Ca2+-dependent epitopes decreased. For example, in cases 4 and 5, 
conventional Dsg3 ELISA index values were increased in the inactive phase, while 
conformational Dsg3 ELISA index values were decreased (Table 1). In case 2, conventional 
Dsg3 ELISA index value showed a gradual decline after entering the inactive phase, while 
conformational Dsg3 ELISA index value showed a rapid decline (Fig. 3). However, in cases 
7 and 8, both conventional and conformational Dsg3 ELISA index values were decreased 
(Table 1), while the ratio of antibodies against the Ca2+-dependent epitopes increased (Fig. 
4). Alternatively, in all cases, conformational Dsg3 ELISA index values were decreased, but 
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did not show negative in the inactive phase. It is possible that pathogenic antibodies 
against the Ca2+-dependent epitopes decreased after entering the inactive phase, and 
nonpathogenic antibodies against the Ca2+-dependent epitopes, such as AK 15 and AK18 
mAbs, were detected. EDTA-treated ELISA could distinguish antibodies against 
Ca2+-dependent epitopes from non-Ca2+-dependent epitopes of Dsg3, but could not 
distinguish pathogenic from nonpathogenic antibodies against the Ca2+-dependent epitopes. 
Another possible explanation is that low-dose prednisolone and/or adjuvant therapy 
suppressed the disease activity. It is also possible that in mucocutaneous-type PV patients 
the decrease of anti-Dsg1 serum antibodies led to the clinical improvement. 
To evaluate the pathogenicity of PV-IgG associated with EDTA-treated Dsg3 ELISA, we 
examined the pathogenicity of antibodies against Ca2+-dependent and non-Ca2+-dependent 
epitopes of Dsg3 using dissociation assay. The ability of baculoproteins to adsorb 
autoantibodies was restored after EDTA-treated Dsg3 baculoproteins were dialyzed against 
PBS-Ca. We confirmed that the effect of EDTA on the Ca2+-dependent structure of Dsg3 
was reversible, as previously reported 23. The result of the cell-cell dissociation induced by 
PV-IgG after immunoadsorption with each Dsg3 baculoprotein suggests that antibodies 
against the Ca2+-dependent epitopes of Dsg3 mainly contribute to the pathogenicity of 
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PV-IgG. Moreover, the antibodies against the non-Ca2+-dependent epitopes of Dsg3 were 
nonpathogenic, and did not enhance the effects on disruption of intercellular adhension as 
far as determined by in vitro dissociation assay. 
A previous study showed that IgG titers against NH2-terminus of Dsg3 (1-161) (Fig. 1) 
correlated with the disease activity of PV 24. In addition to pathogenic antibodies against 
NH2-terminus of Dsg3 (1-161), antibodies against the EC2, EC3 and EC4 may act 
synergistically in inducing the intraepidermal loss of adhesion and decreased with the 
improvement of the disease 25. Moreover, antibodies against the EC1 and EC5 were 
detected in the inactive phase, while antibodies against the EC2, EC3 and EC4 were not. 
EDTA-treated ELISA can distinguish antibodies against Ca2+-dependent epitopes (i.e. Dsg3 
(1-161)) and non-Ca2+-dependent epitopes (i.e. Dsg3 (403-565)). Therefore, EDTA-treated 
ELISA can be useful for detecting pathogenic anti-Dsg3 serum antibodies more accurately 
in clinical situations, especially in the inactive phase of PV. When the dose of prednisolone 
or immunosuppressive drugs is tapered, EDTA-treated ELISA provides a clearer indication 
of what proportion of anti-Dsg3 serum antibody titer is composed of pathogenic antibodies. 
Moreover, when a rise in anti-Dsg3 serum antibody titers before a disease relapse was 
observed, the ratio of antibodies against the Ca2+-dependent epitopes or the 
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non-Ca2+-dependent epitopes would be useful information to predict the disease activity. 
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Figure legends 
Fig 1. Molecular structure of Dsg3 and the epitopes recognized by various AK mAbs. 
The epitopes recognized by AK mAbs were mapped by immunoprecipitation of 
domain-swapped Dsg3 recombinant molecules 12. 
 
Fig 2. Affinity of each anti-Dsg3 mAb to the 0.5 mM EDTA-treated Dsg3 recombinant 
protein. 
EDTA-treated ELISA index values for AK23 (a) and AK19 (b) mAbs directed against the 
Ca2+-dependent conformational epitopes decreased markedly compared to conventional 
ELISA index values. However, the affinity of AK20 (e) mAb directed against the 
non-Ca2+-dependent epitopes was not affected. 
 
Fig 3. Conformational ELISA index values of 8 PV patients’ sera, which remained elevated 
conventional Dsg3 ELISA index values greater than 100 index values even in the inactive 
phase. 
Anti-Dsg3 ELISA index values as determined using conventional ELISA for 8 patients in 
the active phase of PV were decreased, but remained high after they entered the inactive 
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phase. Anti-Dsg3 ELISA index values were increased in 2 patients after entering the 
inactive phase. On the other hand, calculated conformational ELISA index values were 
decreased in all patients. 
 
Fig 4. The ratio of anti-Dsg3 serum antibodies recognizing Ca2+-dependent and 
non-Ca2+-dependent epitopes in active and inactive phases. 
The ratio of antibodies recognizing the Ca2+-dependent epitopes decreased in 6 out of the 
8 patients after entering the inactive phase. 
 
Fig 5. Dose-dependent effects of purified IgG from PV patients’ sera with different 
conformational ELISA index values on disruption of intercellular adhension. 
  Monolayers of DJM-1 cells were treated with each purified IgG at concentrations 
between 0.032 and 1000 µg/ml. Purified IgG in case 1, which were obtained in the active 
phase and contained antibodies against the Ca2+-dependent epitopes, showed 
dose-dependent reactivity between 4 and 1000 µg/ml. Purified IgG in case 2, which did not 
have pathogenicity clinically and had no antibodies against the Ca2+-dependent epitopes, 
did not induce fragmentations of the cell sheet. 
30 
 
 
Fig. 6 Effects of PV-IgG against non-Ca2+-dependent epitopes on disruption of intercellular 
adhension. 
Purified IgG were obtained from 2 PV patients (No. 1, 2 and No. 3, 4). Cell sheets were 
incubated with each PV-IgG for 8 hours (a) and 24 hours (b). The number of cell 
fragmentations incubated with PV-IgG No. 1 was nearly equal to that of PV-IgG No. 2. 
Similarly, the number of cell fragmentations incubated with PV-IgG No. 3 was nearly equal 
to that of PV-IgG No. 4. 
 
Fig. 7 Alteration of the immunoreactivity of PV-IgG after immunoadsorption with each 
Dsg3 baculoprotein. 
  PV-IgG were incubated with each Dsg3 baculoprotein. As the concentrations of untreated 
Dsg3 baculoproteins and EDTA-treated Dsg3 baculoproteins dialyzed against PBS-Ca 
increased, the immunoreactivities of PV-IgG were strongly blocked. On the other hand, the 
immunoreactivity of PV-IgG adsorbed with EDTA-treated Dsg3 baculoproteins reached a 
plateau level, and that was nearly equal to conformational ELISA index value of PV-IgG. 
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Fig 8. Blocking effects of various Dsg3 baculoprotein treatments on dissociation assay. 
Cell sheets incubated with EDTA-treated Dsg3-adsorbed PV-IgG (b) dissociated into 
numerous smaller fragments, with the number of fragmentations equal to that of the 
positive control (a). By contrast, PV-IgG adsorbed with untreated Dsg3 baculoproteins (d) 
and PV-IgG adsorbed with EDTA-treated Dsg3 baculoproteins dialyzed against PBS-Ca (c) 
did not cause fragmentations, as well as the negative control (e). The cell fragmentations 
were quantified as shown in the graph. 
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Table 
Table 1. Antibody profiles of the serum from PV patients with anti-Dsg3 ELISA index value 
greater than 100 index value in the inactive phase. 
 
A: Conventional ELISA index value. 
B: EDTA-treated ELISA index value. 
C: Conformational ELISA index value = conventional ELISA index value－EDTA-treated 
ELISA index value (A－B). 
 
  
33 
 
Table 2. Antibody profiles of the serum from PV patients used for in vitro dissociation assay. 
a) 
 
 
b) 
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